COMP <GO>
ALAB vs NXPI // EV/EBITDA & P/E VALUATION
Astera Labs Inc. (NASDAQ) VS. NXP Semiconductors N.V. (NASDAQ) • 15-METRIC TALLY: ALAB 6
— NXPI 7
▲ EV/EBITDA & P/E VALUATION LEADER: NXPI
LAST: $258.70 (-10.92%) • MKT CAP: $50.39B
valuation
95.0x
LAST: $259.61 (-2.40%) • MKT CAP: $67.05B
valuation
22.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALAB VS. NXPI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALAB | NXPI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.70% | 54.70% | +21.00 | ALAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | 13.60% | -10.20 | NXPI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 95.0x | 22.1x | +72.90 | NXPI | /valuation <GO> |
| Free Cash Flow Yield | 0.56% | 3.61% | -3.05 | NXPI | /fcf-yield <GO> |
| Operating Margin | 20.30% | 24.80% | -4.50 | NXPI | /operating-margins <GO> |
| Net Profit Margin | 25.70% | 16.50% | +9.20 | ALAB | /net-margins <GO> |
| Revenue Growth (YoY) | 115.10% | -2.70% | +117.80 | ALAB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.53% | -1.53 | NXPI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.45 | +22.55 | ALAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ALAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.4 | 66.8 | -19.40 | NXPI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.15 | +0.19 | ALAB | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 30.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.39B | $67.05B | -$16.66B | NXPI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALAB REV | NXPI REV | ALAB GROSS % | NXPI GROSS % | ALAB FCF | NXPI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $852.5M | $12.27B | 75.7% | 54.7% | $281.8M | $2.42B |
| FY 2024 | $396.3M | $12.61B | 76.4% | 56.4% | $102.4M | $2.06B |
| FY 2023 | $115.8M | $13.28B | — | — | -$17.9M | $2.92B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALAB // BETA 1.34
NXPI // BETA 1.15